Advertisement

Advances in Therapy

, Volume 18, Issue 3, pp 101–109 | Cite as

Impulse magnetic-field therapy for migraine and other headaches: A double-blind, placebo-controlled study

  • Rainer B. Pelka
  • Christof Jaenicke
  • Joerg Gruenwald
Article

Abstract

This double-blind, placebo-controlled study assessed the efficacy of 4 weeks of impulse magnetic-field therapy (16 Hz, 5 μTs), delivered through a small device, for different types of headache and migraine. Eighty-two patients were randomly assigned to receive either active treatment or placebo (n = 41 each) and were characterized according to one of seven diagnoses (migraine, migraine combined with tension, tension, cluster, weather-related, posttraumatic, or other). Efficacy was assessed in terms of duration, severity, and frequency of migraine and headache attacks, as well as ability to concentrate. Data for77 patients were analyzed. In the active-treatment group, all assessed criteria were significantly improved at the end of the study (P<.0001 vs baseline and placebo). Seventy-six percent of active-treatment patients experienced clear or very clear relief of their complaints. Only 1 placebo-patient (2.5%) felt some relief; 8% noted slight and 2% reported significant worsening of symptoms. No side effects were noted.

Keywords

headache migraine meteorosensitivity alternative therapy impulse magnetic-field therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guyton AC, Hall JE. Somatic sensations, II: pain, headache, and thermal sensations. In:Textbook of Medical Physiology. 9th ed. Philadelphia: WB Saunders; 1996:617–619.Google Scholar
  2. 2.
    Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample.Headache. 1992;32:237–238.CrossRefGoogle Scholar
  3. 3.
    Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies.Neurology. 1994;44(6,suppl 4):S17-S23.PubMedGoogle Scholar
  4. 4.
    Stewart WF, Lipton RB. Migraine headache: epidemiology and health care utilisation.Cephalalgia. 1993;3(suppl 12):41–46.Google Scholar
  5. 5.
    De Lissvoy G, Lazarus SS. The economic cost of migraine: present state of knowledge.Neurology. 1994;44(6, suppl 4):S56-S62.Google Scholar
  6. 6.
    Böhmig U.Kopfschmerz und Migräne. Vienna: Orac Verlag; 1988.Google Scholar
  7. 7.
    Kniep P.Migräne und Gesundheit. Munich: Herder; 1987.Google Scholar
  8. 8.
    Pfaffenrath V.Was ist Gesichert in der Therapie?Der chronische Kopfschmerz—Spannungskopfschmerz und Schmerzmittelmiflbrauch. Munich: Arcis Verlag; 1988.Google Scholar
  9. 9.
    Sicuteri F, Del Bianco PL, Anselmi B. Morphine abstinence and serotonin supersensitivity in man: analogies with the mechanism of migraine?Psychopharmacology, Berlin. 1979;65:205–209.CrossRefGoogle Scholar
  10. 10.
    Raskin VH. Headache. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds.Harrison’s Principles of Internal Medicine. 12th ed. New York: McGraw-Hill; 1991:108–115.Google Scholar
  11. 11.
    Silberstein STD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review).Neurology. 2000;55:754–763.PubMedGoogle Scholar
  12. 12.
    National Institute of Neurological Disorders and Stroke. NINDS headache information page. Bethesda, Md: National Institutes of Health; 2000. Available at: www.ninds.nih.gov.Google Scholar
  13. 13.
    Oleson J. Classification and diagnostic criteria for headache disorders. Cranial neuralgias and facial pain.Cephalalgia. 1988;8(suppl 7):19–28.Google Scholar
  14. 14.
    Tiuriaeva AA, Ponizovskii VM, Akimov GL. Effects of alternating field on healing of ulcers of the lower extremities.Vestn Khir Im I I Grek. 1977;119:84–85.PubMedGoogle Scholar
  15. 15.
    Barnothy M.Biological Effects of Magnetic Fields. New York: Plenum Press; 1969.Google Scholar
  16. 16.
    Bassett CA, Pilla AA, Pawluk RJ. A non-operative salvage of surgically-resistant pseudoarthroses and non-unions by pulsing electromagnetic fields. A preliminary report.Clin Orthop. 1977; 124:128–143.PubMedGoogle Scholar
  17. 17.
    Bergsmann O. Selektive Feldtherapie bei pseudoradikulären Symptomen.Manuella Med. 1983; 21:139.Google Scholar
  18. 18.
    Cameron H, et al. An examination of the effects of pulsed magnetic fields on knee swelling following total knee replacement. Presented at: International Congress on Foot and Hand Surgery; 1981; São Paulo, Brazil.Google Scholar
  19. 19.
    Ehrmann W, et al. Therapie mit ELF-Magnetfeldern.Z Phys Med. 1976;4: 161–170.Google Scholar
  20. 20.
    Evertz U, König H. Pulsierende magnetische Felder in ihrer Bedeutung für die Medizin.Hippokrates. 1977;1:16.Google Scholar
  21. 21.
    Hainovici N. Beeinflussung der Kallusbildung unter der Behandlung mit niederfrequenten gepulsten magnetfeldern.Therapiewoche. 1987;30:4619–4631.Google Scholar
  22. 22.
    Watson J, Downes E. Clinical aspects of the stimulation of bone healing using electrical phaenomena.Med Ant Biot Ent Comp. 1979;17:261.Google Scholar
  23. 23.
    Warnke U. Grundlagen zu magnetisch induzierten physiologischen Effekten.Therapiewoche. 1980;30:4609–4616.Google Scholar

Copyright information

© Health Communications Inc 2001

Authors and Affiliations

  • Rainer B. Pelka
    • 1
  • Christof Jaenicke
    • 2
  • Joerg Gruenwald
    • 2
  1. 1.Universität der Bundeswehr MünchenMunichGermany
  2. 2.PhytoPharm ConsultingInstitute for PhytopharmaceuticalsBerlinGermany

Personalised recommendations